208
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Cell wall permeability assisted virtual screening to identify potential direct InhA inhibitors of Mycobacterium tuberculosis and their biological evaluation

, &
Pages 3274-3290 | Received 23 Jul 2017, Accepted 20 Sep 2017, Published online: 20 Oct 2017

References

  • Arvind, A., Kumar, V., Saravanan, P., & Mohan, C. G. (2012). Homology modeling, molecular dynamics and inhibitor binding study on MurD ligase of Mycobacterium tuberculosis. Interdisciplinary Sciences, Computational Life Sciences, 4, 223–238.10.1007/s12539-012-0133-x
  • Awale, M., Kumar, V., Saravanan, P., & Mohan, C. G. (2010). Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors. Journal of Molecular Modeling, 16, 475–488.10.1007/s00894-009-0565-3
  • Böhm, H.-J., Flohr, A., & Stahl, M. (2004). Scaffold hopping. Drug discovery today: Technologies, 1, 217–224.10.1016/j.ddtec.2004.10.009
  • Camenisch, G., Alsenz, J., van de Waterbeemd, H., & Folkers, G. (1998). Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight. European Journal of Pharmaceutical Sciences, 6, 313–319.10.1016/S0928-0987(97)10019-7
  • Cantrell, C. L., Lu, T., Fronczek, F. R., Fischer, N. H., Adams, L. B., & Franzblau, S. G. (1996). Antimycobacterial cycloartanes from Borrichia frutescens. Journal of Natural Products, 59, 1131–1136.10.1021/np960551w
  • Case, D. A., Darden, T., Cheatham, T., Simmerling, C. L., Wang, J., Duke, R. E., … Merz, K. (2010). Amber 11. (p. 142). San Francisco, CA: University of California.
  • Cortes, C., & Vapnik, V. (1995). Support-vector networks. Machine learning, 20, 273–297.
  • Cruciani, G., Pastor, M., & Guba, W. (2000). VolSurf: A new tool for the pharmacokinetic optimization of lead compounds. European Journal of Pharmaceutical Sciences, 11, S29–S39.10.1016/S0928-0987(00)00162-7
  • Dey, R., & Chen, L. (2011). In search of allosteric modulators of α7-nAChR by solvent density guided virtual screening. Journal of Biomolecular Structure and Dynamics, 28, 695–715.10.1080/07391102.2011.10508600
  • Doucet, J.-P., Barbault, F., Xia, H., Panaye, A., & Fan, B. (2007). Nonlinear SVM approaches to QSPR/QSAR studies and drug design. Current Computer-Aided Drug Design, 3, 263–289.10.2174/157340907782799372
  • DUD, A. (Accessed, 2012).
  • Gasteiger, J., & Zupan, J. (1993). Neural networks in chemistry. Angewandte Chemie International Edition in English, 32, 503–527.10.1002/(ISSN)1521-3773
  • Gautam, R., Jachak, S. M., Kumar, V., & Mohan, C. G. (2011). Synthesis, biological evaluation and molecular docking studies of stellatin derivatives as cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters, 21, 1612–1616.10.1016/j.bmcl.2011.01.116
  • Grover, J., Bhatt, N., Kumar, V., Patel, N. K., Gondaliya, B. J., Elizabeth Sobhia, M. E., … Jachak, S. M. (2015). 2, 5-Diaryl-1, 3, 4-oxadiazoles as selective COX-2 inhibitors and anti-inflammatory agents. RSC Advances, 5, 45535–45544.10.1039/C5RA01428 J
  • Grover, J., Kumar, V., Singh, V., Bairwa, K., Sobhia, M. E., & Jachak, S. M. (2014a). Synthesis, biological evaluation, molecular docking and theoretical evaluation of ADMET properties of nepodin and chrysophanol derivatives as potential cyclooxygenase (COX-1, COX-2) inhibitors. European Journal of Medicinal Chemistry, 80, 47–56.10.1016/j.ejmech.2014.04.033
  • Grover, J., Kumar, V., Sobhia, M. E., & Jachak, S. M. (2014b). Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno [4, 3-c] pyrazol-4 (1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors. Bioorganic & Medicinal Chemistry Letters, 24, 4638–4642.10.1016/j.bmcl.2014.08.050
  • He, X., Alian, A., & Ortiz de Montellano, P. R. (2007). Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. Bioorganic & Medicinal Chemistry, 15, 6649–6658.10.1016/j.bmc.2007.08.013
  • He, X., Alian, A., Stroud, R., & Ortiz de Montellano, P. R. (2006). Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. Journal of Medicinal Chemistry, 49, 6308–6323.10.1021/jm060715y
  • Hevener, K. E., Cao, S., Zhu, T., Su, P.-C., Mehboob, S., & Johnson, M. E. (2013). Special challenges to the rational design of antibacterial agents. Annual Reports in Medicinal Chemistry, 48, 283–298.10.1016/B978-0-12-417150-3.00018-1
  • Hevener, K. E., Mehboob, S., Su, P.-C., Truong, K., Boci, T., Deng, J., … Johnson, M. E. (2011). Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matching. Journal of Medicinal Chemistry, 55, 268–279.
  • Kumar, V., Saravanan, P., Arvind, A., & Mohan, C. G. (2011). Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques. Journal of Molecular Modeling, 17, 939–953.10.1007/s00894-010-0788-3
  • Kumar, A., & Siddiqi, M. I. (2008). CoMFA based de novo design of pyrrolidine carboxamides as inhibitors of enoyl acyl carrier protein reductase from Mycobacterium tuberculosis. Journal of Molecular Modeling, 14, 923–935.10.1007/s00894-008-0326-8
  • Kumar, V., & Sobhia, M. E. (2013). Characterisation of the flexibility of substrate binding loop in the binding of direct InhA inhibitors. International Journal of Computational Biology and Drug Design, 6, 318–342.10.1504/IJCBDD.2013.056795
  • Kumar, V., & Sobhia, M. E. (2014). Insights into the bonding pattern for characterizing the open and closed state of the substrate-binding loop in Mycobacterium tuberculosis InhA. Future Medicinal Chemistry, 6, 605–616.10.4155/fmc.14.27
  • Kumar, V., & Sobhia, M. E. (2015). Molecular dynamics assisted mechanistic study of isoniazid-resistance against Mycobacterium tuberculosis InhA. PLoS ONE, 10, e0144635.10.1371/journal.pone.0144635
  • Kumar, V., & Sobhia, M. E. (2016). Molecular dynamics-based investigation of InhA substrate binding loop for diverse biological activity of direct InhA inhibitors. Journal of Biomolecular Structure and Dynamics, 34, 2434–2452.10.1080/07391102.2015.1118410
  • Kuo, M. R., Morbidoni, H. R., Alland, D., Sneddon, S. F., Gourlie, B. B., Staveski, M. M., … Yee, C. (2003). Targeting tuberculosis and malaria through inhibition of enoyl reductase compound activity and structural data. Journal of Biological Chemistry, 278, 20851–20859.10.1074/jbc.M211968200
  • Labute, P. (2000). A widely applicable set of descriptors. Journal of Molecular Graphics and Modelling, 18, 464–477.10.1016/S1093-3263(00)00068-1
  • Lu, X.-Y., Chen, Y.-D., Jiang, Y.-J., & You, Q.-D. (2009). Discovery of potential new InhA direct inhibitors based on pharmacophoreand 3D-QSAR analysis followed by in silico screening. European Journal of Medicinal Chemistry, 44, 3718–3730.10.1016/j.ejmech.2009.03.043
  • Lu, X. Y., Chen, Y. D., & You, Q. D. (2010). 3D-QSAR studies of arylcarboxamides with inhibitory activity on InhA using pharmacophore-based alignment. Chemical Biology & Drug Design, 75, 195–203.10.1111/jpp.2009.75.issue-2
  • Luckner, S. R., Liu, N., am Ende, C. W., Tonge, P. J. & Kisker, C. (2010). A slow, tight binding inhibitor of inha, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis. Journal of Biological Chemistry, 285, 14330–14337.10.1074/jbc.M109.090373
  • Maganti, L., Ghoshal, N. & Ghoshal, N. (2015). 3D-QSAR studies and shape based virtual screening for identification of novel hits to inhibit MbtA in Mycobacterium tuberculosis. Journal of Biomolecular Structure and Dynamics, 33, 344–364.10.1080/07391102.2013.872052
  • Molecular Operating Environment (MOE). (2006). C. C. G. I., 1010 Sherbooke St. West, Suite #910, Montreal, QC H3A 2R7, 2015.
  • Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19, 1639–1662.10.1002/(ISSN)1096-987X
  • OEChem, T. (2012). OpenEye scientific software. Santa Fe, NM: Inc.
  • Peterson, K. L. (2000). Artificial neural networks and their use in chemistry. Reviews in Computational Chemistry, 16, 53–140.10.1002/SERIES6143
  • Prasanth Kumar, S., Jasrai, Y. T., Pandya, H. A., & Rawal, R. M. (2015). Pharmacophore-similarity-based QSAR (PS-QSAR) for group-specific biological activity predictions. Journal of Biomolecular Structure and Dynamics, 33, 56–69.10.1080/07391102.2013.849618
  • Sharma, V., & Wakode, S. (2017). Structural insight into selective phosphodiesterase 4B inhibitors: Pharmacophore-based virtual screening, docking, and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 35, 1339–1349.10.1080/07391102.2016.1183520
  • Singh, A., Paliwal, S., Sharma, M., Mittal, A., Sharma, S., Tripathi, N., & Tilak, A. (2017). Identification of novel antifungal lead compounds through pharmacophore modeling, virtual screening, molecular docking, antimicrobial evaluation, and gastrointestinal permeation studies. Journal of Biomolecular Structure and Dynamics, 35, 2363–2371.10.1080/07391102.2016.1218369
  • Studio, D. (2009). version 2.5; Accelrys. San Diego, CA: Inc., 92121.
  • Su, P. C., & Johnson, M. E. (2016). Evaluating thermodynamic integration performance of the new amber molecular dynamics package and assess potential halogen bonds of enoyl-ACP reductase (FabI) benzimidazole inhibitors. Journal of Computational Chemistry, 37, 836–847.10.1002/jcc.v37.9
  • Su, P. C., Tsai, C. C., Mehboob, S., Hevener, K. E., & Johnson, M. E. (2015). Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI). Journal of Computational Chemistry, 36, 1859–1873.10.1002/jcc.v36.25
  • Witten, I. H., & Frank, E. (2005). Data Mining: Practical machine learning tools and techniques. Morgan Kaufmann.
  • Wythoff, B. J. (1993). Backpropagation neural networks: A tutorial. Chemometrics and Intelligent Laboratory Systems, 18, 115–155.10.1016/0169-7439(93)80052-J
  • Zhu, T., Cao, S., Su, P.-C., Patel, R., Shah, D., Chokshi, H. B., … Hevener, K. E. (2013). Hit identification and optimization in virtual screening: Practical recommendations based on a critical literature analysis: Miniperspective. Journal of Medicinal Chemistry, 56, 6560–6572.10.1021/jm301916b
  • Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P., Cole, S. T., Abubakar, I., … Nunn, A. J. (2014). New antituberculosis drugs, regimens, and adjunct therapies: Needs, advances, and future prospects. The Lancet Infectious Diseases, 14, 327–340.10.1016/S1473-3099(13)70328-1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.